NEW YORK (GenomeWeb News) — The Japanese Red Cross will use Roche’s PCR-based testing devices to screen the nation’s supply of donated blood for HIV and hepatitis B and C, the company said today.
 
Roche said it will supply next-generation nucleic acid-screening products to accommodate Japan’s 5 million annual blood donations. The tools will comprise Roche’s Cobas 401 and its TaqScreen MPX test, which can detect HIV-1, HIV-2, and hepatitis B and C viruses.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.